21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
10.86.Z - Production of homogenized food products and diet food
10.89.Z - Production of other food products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
46.38.Z - Wholesale trade of other food products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.91.Z - Intermediary retail sale, non-specialized
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 44,2 | |||
Gross profit (loss) | -0,8 | -2,2 | -0,9 | 58,6 |
EBITDA | -0,5 | -1,6 | -0,6 | 60,9 |
Short time liabilities | 4,7 | 6 | 7,4 | 23,2 |
Other operating costs | 365,9 | |||
Equity capital | -6 | -8,2 | -9,1 | -11,1 |
Operating profit (EBIT) | -0,7 | -1,8 | -0,8 | 55,6 |
Assets | 5,3 | 4,6 | 4,5 | -3,4 |
Net profit (loss) | -0,8 | -2,2 | -0,9 | 58,6 |
Cash | 0,2 | 0 | 0,1 | 3739,9 |
Net income from sale | 5,2 | 3,4 | 3,4 | -1,7 |
Liabilities and provisions for liabilities | 11,3 | 12,8 | 13,5 | 5,9 |
Working assets | 2,7 | 2,2 | 2,3 | 1,2 |
Other income costs | 1462,9 | |||
Depreciation | 0,2 | 0,3 | 0,2 | -23,9 |
% | % | % | p.p. | |
Profitability of capital | -72,9 | |||
Equity capital to total assets | -111,6 | -176,8 | -203,5 | -26,7 |
Gross profit margin | -14,7 | -64,2 | -27,1 | 37,1 |
EBITDA Margin | -8,7 | -45,2 | -18 | 27,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 591 | |||
Current financial liquidity indicator | 0.576409637928009 | 0.37395310401916504 | 0.3071301579475403 | -0,1 |
Net dept to EBITDA | -3,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane